glp-1 and cancer risk Glucagon-like peptide 1 receptor agonists risk: the good, the bad and the unknown VisualAbstract: Glucagon-like peptide 1 receptor
Description
Eligibility for any treatment is determined by a licensed clinician on a case-by-case basis
Large clinical trials have reinforced these recommendations
Many healthcare professionals and patients find it helpful to start GLP-1 therapy at the beginning of a weekend or during a period of reduced work or social commitments
Lastly, this study highlighted the decrease in brain inflammation and marked increase in glial cell activation [61], again illustrating the anti-inflammatory and neuroprotective properties of GLP-1
Side Effects to Consider Like all medications, GLP-1 and Wegovy may have side effects
